(ANSA) - MOSCOW, 06 MAY - The single-dose version of the Sputnik V vaccine, called Sputnik Light, was registered in Russia. This was announced by the Russian Fund for Direct Investments (Rdif) in a note.
"The single-dose Sputnik Light vaccine demonstrated efficacy of 79.4% according to data analyzed after 28 injection in the framework of Russia's mass vaccination program between December 5, 2020 and April 15, 2021," the statement reads. "An efficacy level of nearly 80% is higher than that of many two-dose vaccines. Sputnik Light has proven effective against all new coronavirus strains, as demonstrated by the Gamaleya Center during laboratory tests," it reads.
"On February 21, 2021, Gamaleya Center and Rdif launched a global efficacy study of Sputnik Light. The Phase III clinical study, involving 7,000 people, is being conducted in several countries including Russia, the United Arab Emirates, Ghana and others. Intermediate results are expected. for May 2021 ", continues the note.
"Sputnik Light will help prevent the spread of coronavirus through faster immunization of larger population groups, as well as supporting high levels of immunity in those who have previously been infected," said Alexander Gintsburg, director of the Gamaleya center. "Sputnik Light offers strong value in initial vaccination and revaccination, as well as enhancing efficacy when taken in combination with other vaccines." (HANDLE).